Listar por tema "Venous Thromboembolism"

Analysis of the quality of reporting of randomized controlled trials in anticoagulant versus antiplatelet medication for venous thromboembolism prophylaxis as governed by the CONSORT statement

Beneki E., Vrysis C., Zintzaras E., Doxani C. (2021)

Randomized controlled trials (RCTs) are the gold standard research in evaluating healthcare interventions. The CONSORT (Consolidated Standards of Reporting Trials) statement improves the quality of RCTs in an evidence-based ...

Anticoagulation for Thromboprophylaxis in Patients with Intracerebral Hemorrhage: Less Room for Skepticism

Proietti M., Ntaios G. (2022)

[No abstract available]

Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement

Liampas I., Chlinos A., Siokas V., Brotis A., Dardiotis E. (2019)

Randomized controlled trials (RCTs) are the cornerstone of evidence based medicine. Ιt is crucial that RCTs have transparent reporting to facilitate their interpretation. The purpose of the present study is the evaluation ...

Bilateral Deep Vein Thrombosis and Pulmonary Embolism Due to Right Common Iliac Artery Aneurysm with a Contained Rupture

Malli F., Dimeas I.E., Sinis S.I., Karetsi E., Nana P., Kouvelos G., Gourgoulianis K.I. (2022)

Venous thromboembolism (comprising deep venous thrombosis and/or pulmonary embolism) is a common disease, often of multifactorial cause. Focal iliac artery aneurysms are relatively rare, and only a few reports exist in the ...

Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression

Sagris D., Leventis I., Georgiopoulos G., Korompoki E., Makaritsis K., Vemmos K., Milionis H., Lip G.Y.H., Ntaios G. (2020)

Background: A considerable proportion of patients with atrial fibrillation (AF) are still treated with aspirin despite current guidelines due to presumed favorable safety. Aim: We performed a systematic review and meta-analysis ...

COVID-19 hemodynamic and thrombotic effect on the eye microcirculation after hospitalization: A quantitative case-control study

Koutsiaris A.G., Riri K., Boutlas S., Panagiotou T.N., Kotoula M., Daniil Z., Tsironi E.E. (2022)

BACKGROUND OBJECTIVE: To quantify the hemodynamic and thrombotic effect of COVID-19 on the eye microcirculation of patients with thromboprophylaxis, shortly after hospital discharge. METHODS: This case-control study included ...

Frequency and predictors of chemotherapy-associated venous thromboembolism: The prospective PREVENT study

Kakkos S.K., Arnaoutoglou E., Tsolakis I.A., Giannoukas A., Papadimitriou C.A., Kentepozidis N., Boukovinas I., Kalofonos H.P., Labropoulos N., Matsagkas M. (2020)

Background: Our knowledge on the burden of symptomatic and asymptomatic venous thromboembolism (VTE) in patients with cancer undergoing chemotherapy is limited. The aim of our study was to prospectively investigate the ...

New prophylaxis strategies to reduce the risk of thromboembolism in cancer

Papadopoulos V., Tsapakidis K., Markou A., Kokkalis A., Aidarinis C., Kotsakis A. (2021)

Introduction: Patients with cancer are at risk of thrombotic events, mainly deep vein thrombosis and/or pulmonary embolism. The thrombosis risk is generally 4–6 times higher than in a healthy population and depends on ...

Obesity as a Risk Factor for Venous Thromboembolism Recurrence: A Systematic Review

Ntinopoulou P., Ntinopoulou E., Papathanasiou I.V., Fradelos E.C., Kotsiou O., Roussas N., Raptis D.G., Gourgoulianis K.I., Malli F. (2022)

Background and Objectives: Venous thromboembolism (VTE) encompasses Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE). The duration of anticoagulant therapy following a VTE event partly relies on the risk of recurrent ...

Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update

Akrivou D., Perlepe G., Kirgou P., Gourgoulianis K.I., Malli F. (2022)

The aim of this review is to highlight all the factors that associate venous thromboembolism (VTE) with aging. Elderly people are characterized by a higher incidence of thrombosis taking into account the co-existing ...

Perioperative management of DOACs in vascular surgery: A practical approach

Kouvelos G., Matsagkas M., Rousas N., Nana P., Mpatzalexis K., Stamoulis K., Giannoukas A., Arnaoutoglou E. (2018)

Background: Approximately 10–15% of patients on DOACs have to interrupt their anticoagulant before an invasive procedure every year. The perioperative management and monitoring of DOACs have proved to be challenging, as ...

Real world data regarding the management of cancer-associated thrombosis

Tsoukalas N., Tsapakidis K., Galanopoulos M., Karamitrousis E., Kamposioras K., Tolia M. (2020)

PURPOSE OF REVIEW: Patients with cancer are at high risk for thrombotic events, mainly deep vein thrombosis and pulmonary embolism. Low-molecular-weight heparins (LMWHs) and direct oral anticoagulants (DOACs) are among the ...

Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode

Karathanos C., Spanos K., Giannoukas A. (2018)

[No abstract available]

The role of direct oral anticoagulants in cancer-associated thrombosis according to the current literature

Nana P., Dakis K., Peroulis M., Rousas N., Spanos K., Kouvelos G., Arnaoutoglou E., Matsagkas M. (2021)

Venous thromboembolism (VTE) is a common complication among patients suffering from malignancies, leading to an increased mortality rate. Novel randomized trials have added valuable information regarding cancer-associated ...

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19

Luo S., Vasbinder A., Du-Fay-de-lavallaz J.M., Gomez J.M.D., Suboc T., Anderson E., Tekumulla A., Shadid H., Berlin H., Pan M., Azam T.U., Khaleel I., Padalia K., Meloche C., O’hayer P., Catalan T., Blakely P., Launius C., Amadi K.-M., Pop-Busui R., Loosen S.H., Chalkias A., Tacke F., Giamarellos-Bourboulis E.J., Altintas I., Eugen-Olsen J., Williams K.A., Volgman A.S., Reiser J., Hayek S.S., on behalf of the ISIC (International Study of Inflammation in COVID-19) Group (2022)

BACKGROUND: Venous thromboembolism (VTE) contributes significantly to COVID-19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation. Levels of soluble urokinase plasminogen ...

Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports

Kyriakoulis K.G., Kollias A., Kyriakoulis I.G., Kyprianou I.A., Papachrysostomou C., Makaronis P., Kotronias R.A., Terentes-Printzios D., Toskas I., Mikhailidis D.P. (2022)

Background: Venous Thromboembolism (VTE) is common among patients with severe Coronavirus Disease 2019 (COVID-19). Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefit; however, the ...